Board Meeting21 May 2026, 05:51 pm
Kabra Drugs Board Meeting on May 29, 2026 to Approve Results
AI Summary
Kabra Drugs Ltd has scheduled a Board of Directors meeting on May 29, 2026, to consider and approve the unaudited financial results for the quarter ended March 31, 2026. The meeting will also address any other agenda items with the chair's permission. The trading window for dealing in the company's shares has been closed until 48 hours after the announcement of the financial results.
Key Highlights
- Board meeting scheduled for May 29, 2026, in Chennai.
- Meeting to approve unaudited financial results for quarter ended March 31, 2026.
- Trading window closed until 48 hours post financial results announcement.
- Meeting will address any other agenda with chair's permission.
Price Impact
More from KABRADG